Presse N, Perreault S, Kergoat M-J
Marie-Jeanne Kergoat, MD, Centre de recherche, Institut universitaire de gériatrie de Montréal, 4565 Queen Mary, Montréal, QC Canada H3W 1W5, Telephone: 514-340-2800 #3246, Fax number: 514-340-2801, E-mail address:
J Nutr Health Aging. 2016;20(5):569-73. doi: 10.1007/s12603-015-0605-x.
Use of gastric acid inhibitors has emerged as a risk factor of vitamin B12 deficiency, especially in older adults. Calcium supplements could be an effect modifier of this relationship by its role in the absorption process of vitamin B12. The aim of this study is to examine whether the use of calcium supplements could be an effect modifier of the association between gastric acid inhibitors and vitamin B12 deficiency.
Cross-sectional study based on medical chart reviews.
Geriatric Assessment Unit (GAU) of a university-affiliated hospital.
The study included 172 patients discharged from the GAU between 2008 and 2012.
Cases of vitamin B12 deficiency were identified as those who had received a diagnosis of vitamin B12 deficiency, and/or were receiving a treatment for vitamin B12 deficiency. Use of gastric acid inhibitors and calcium supplements at admission was determined from the pharmacist report. Associations between medications and vitamin B12 status were investigated using logistic regression models.
Seventy-one patients (41%) had vitamin B12 deficiency. At admission, 42% were taking gastric acid inhibitors and 45% calcium supplements. After adjustment for covariates, analyses revealed that vitamin B12 deficiency was more likely among users of gastric acid inhibitors who did not concomitantly received calcium supplements [OR=3.12; P=0.01]. Conversely, no significant association was observed in patients using both, gastric acid inhibitors and calcium supplements [OR=1.30; P=0.59].
The present study provides the very first evidence that the use of calcium supplements could be an effect modifier of the association between gastric acid inhibitors and vitamin B12 deficiency. Failure to consider calcium supplements as an effect modifier could have led to biased risk estimates in previous published studies.
使用胃酸抑制剂已成为维生素B12缺乏的一个危险因素,尤其是在老年人中。钙补充剂可能因其在维生素B12吸收过程中的作用而成为这种关系的效应修饰因素。本研究的目的是检验钙补充剂的使用是否可能是胃酸抑制剂与维生素B12缺乏之间关联的效应修饰因素。
基于病历回顾的横断面研究。
一所大学附属医院的老年评估单元(GAU)。
该研究纳入了2008年至2012年间从GAU出院的172例患者。
维生素B12缺乏病例被确定为那些已被诊断为维生素B12缺乏和/或正在接受维生素B12缺乏治疗的患者。入院时胃酸抑制剂和钙补充剂的使用情况根据药剂师报告确定。使用逻辑回归模型研究药物与维生素B12状态之间的关联。
71例患者(41%)存在维生素B12缺乏。入院时,42%的患者正在服用胃酸抑制剂,45%的患者正在服用钙补充剂。在对协变量进行调整后,分析显示,未同时服用钙补充剂的胃酸抑制剂使用者中维生素B12缺乏的可能性更大[比值比(OR)=3.12;P=0.01]。相反,同时使用胃酸抑制剂和钙补充剂的患者未观察到显著关联[OR=1.30;P=0.59]。
本研究提供了首个证据,表明钙补充剂的使用可能是胃酸抑制剂与维生素B12缺乏之间关联的效应修饰因素。在以往发表的研究中,未将钙补充剂视为效应修饰因素可能导致风险估计出现偏差。